118 related articles for article (PubMed ID: 9138439)
1. A comparison of the effects of intravenous pentagastrin on patients with social phobia, panic disorder and healthy controls.
McCann UD; Slate SO; Geraci M; Roscow-Terrill D; Uhde TW
Neuropsychopharmacology; 1997 Mar; 16(3):229-37. PubMed ID: 9138439
[TBL] [Abstract][Full Text] [Related]
2. Effects of the 5-HT3 antagonist, ondansetron, on the behavioral and physiological effects of pentagastrin in patients with panic disorder and social phobia.
McCann UD; Morgan CM; Geraci M; Slate SO; Murphy DL; Post RM
Neuropsychopharmacology; 1997 Dec; 17(6):360-9. PubMed ID: 9397424
[TBL] [Abstract][Full Text] [Related]
3. Anxiety sensitivity in social phobia: comparison between social phobics with and without panic attacks.
Scott EL; Heimberg RG; Jack MS
Depress Anxiety; 2000; 12(4):189-92. PubMed ID: 11195754
[TBL] [Abstract][Full Text] [Related]
4. Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients.
van Megen HJ; Westenberg HG; den Boer JA; Haigh JR; Traub M
Psychopharmacology (Berl); 1994 Apr; 114(3):449-55. PubMed ID: 7855203
[TBL] [Abstract][Full Text] [Related]
5. Flumazenil challenge in social phobia.
Coupland NJ; Bell C; Potokar JP; Dorkins E; Nutt DJ
Depress Anxiety; 2000; 11(1):27-30. PubMed ID: 10723632
[TBL] [Abstract][Full Text] [Related]
6. An examination of syndromal validity and diagnostic subtypes in social phobia and panic disorder.
Gelernter CS; Stein MB; Tancer ME; Uhde TW
J Clin Psychiatry; 1992 Jan; 53(1):23-7. PubMed ID: 1737736
[TBL] [Abstract][Full Text] [Related]
7. [Comorbidity of panic disorder and social phobia].
Seguí J; Salvador L; Canet J; Aragón C; Herrera C
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(2):43-7. PubMed ID: 7625235
[TBL] [Abstract][Full Text] [Related]
8. Anxiogenic effects of pentagastrin in patients with social phobia and healthy controls.
van Vliet IM; Westenberg HG; Slaap BR; den Boer JA; Ho Pian KL
Biol Psychiatry; 1997 Jul; 42(1):76-8. PubMed ID: 9193745
[No Abstract] [Full Text] [Related]
9. Situational panic attacks: impact on distress and impairment among patients with social phobia.
Jack MS; Heimberg RG; Mennin DS
Depress Anxiety; 1999; 10(3):112-8. PubMed ID: 10604084
[TBL] [Abstract][Full Text] [Related]
10. Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal.
Geraci M; Anderson TS; Slate-Cothren S; Post RM; McCann UD
Biol Psychiatry; 2002 Dec; 52(12):1183-9. PubMed ID: 12488064
[TBL] [Abstract][Full Text] [Related]
11. Double-blind comparison of 30 and 60 mg tranylcypromine daily in patients with panic disorder comorbid with social anxiety disorder.
Nardi AE; Lopes FL; Valença AM; Freire RC; Nascimento I; Veras AB; Mezzasalma MA; de-Melo-Neto VL; Soares-Filho GL; King AL; Grivet LO; Rassi A; Versiani M
Psychiatry Res; 2010 Feb; 175(3):260-5. PubMed ID: 20036427
[TBL] [Abstract][Full Text] [Related]
12. Effect of medroxyprogesterone pretreatment on pentagastrin-induced panic symptoms in females with panic disorder.
Le Mellédo J; Jhangri GS; Lott P; Tait GR; McManus K; Geddes M; Chrapko W; Lara N
Psychiatry Res; 2001 Apr; 101(3):237-42. PubMed ID: 11311926
[TBL] [Abstract][Full Text] [Related]
13. Pentagastrin-induced hemoconcentration in healthy volunteers and patients with panic disorder: effect of pretreatment with ethinyl estradiol.
Le Melledo JM; Perez-Parada J; Morrow J; Bellavance F; Lara N; Jahandar F; Granger R; Tait G; McManus K
J Psychopharmacol; 2011 Jan; 25(1):71-7. PubMed ID: 19825898
[TBL] [Abstract][Full Text] [Related]
14. Hyperventilation in panic disorder and social phobia.
Nardi AE; Valença AM; Nascimento I; Mezzasalma MA; Zin WA
Psychopathology; 2001; 34(3):123-7. PubMed ID: 11316957
[TBL] [Abstract][Full Text] [Related]
15. Panic disorder and social anxiety disorder subtypes in a caffeine challenge test.
Nardi AE; Lopes FL; Freire RC; Veras AB; Nascimento I; Valença AM; de-Melo-Neto VL; Soares-Filho GL; King AL; Araújo DM; Mezzasalma MA; Rassi A; Zin WA
Psychiatry Res; 2009 Sep; 169(2):149-53. PubMed ID: 19698996
[TBL] [Abstract][Full Text] [Related]
16. Pentagastrin has panic-inducing properties in obsessive compulsive disorder.
de Leeuw AS; Den Boer JA; Slaap BR; Westenberg HG
Psychopharmacology (Berl); 1996 Aug; 126(4):339-44. PubMed ID: 8878350
[TBL] [Abstract][Full Text] [Related]
17. Peptides and anxiety: a dose-response evaluation of pentagastrin in healthy volunteers.
McCann UD; Slate SO; Geraci M; Uhde TW
Anxiety; 1994-1995; 1(6):258-67. PubMed ID: 9160584
[TBL] [Abstract][Full Text] [Related]
18. Pentagastrin infusions in patients with panic disorder. I. Symptoms and cardiovascular responses.
Abelson JL; Nesse RM
Biol Psychiatry; 1994 Jul; 36(2):73-83. PubMed ID: 7948449
[TBL] [Abstract][Full Text] [Related]
19. A comparison of patients with illness phobia and panic disorder.
Noyes R; Wesner RB; Fisher MM
Psychosomatics; 1992; 33(1):92-9. PubMed ID: 1539109
[TBL] [Abstract][Full Text] [Related]
20. Panic disorder and social phobia: effects of comorbidity on familial transmission.
Fyer AJ; Mannuzza S; Chapman TF; Lipsitz J; Martin LY; Klein DF
Anxiety; 1996; 2(4):173-8. PubMed ID: 9160619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
